Pfizer 's booster vaccination campaign began last month, now the US Food and Drug Administration (FDA) decided that it is time to extend it to Johnson & Johnson and Moderna vaccines as well. People ...

Both candidates combine 2 already licensed vaccines to prevent influenza and COVID-19. Fast Track designation was granted with the aim of addressing the significant individual and health system ...

PARIS – The regimen of recommended vaccine shots for elderly Americans may soon be simplified. The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination ...

The drugmakers that developed the first COVID-19 vaccines hope to save Americans from an extra trip to the pharmacy with a single shot that targets both COVID and the flu. Pfizer and BioNTech announed ...

Vaccine maker Moderna, Inc. (MRNA) said on Wednesday that it has withdrawn its application to the U.S. Food and Drug Administration (FDA) for approval of its seasonal flu-COVID combination vaccine ...

The drug regulator has cleared Serum Institute to begin Phase III trials for a 2-in-1 covid-flu vaccine while simultaneously approving an Omicron-specific booster, marking a transition toward seasonal ...

The Food and Drug Administration on Tuesday outlined new regulatory guidance for future Covid-19 vaccine boosters, setting stricter approval standards for healthy Americans. The agency said it wants ...